We are learning how immune cells respond to disease and how to safely enhance immunity to better control, cure and potentially prevent malignancies and other serious conditions.
Fred Hutch researchers continue developing ways to make immunity-boosting therapies even more effective. They are showing these treatments can induce remissions for patients with advanced tumors and are likely to have broad utility across many cancers.
We are enrolling cancer patients onto clinical trials of adoptive T-cell therapies and a new stem cell transplantation approach that uses specific T-cell subsets.
Fred Hutch researchers are showing how normal immune cell responses are controlled and how to use immune cells to produce stable remissions for many patients whose cancers cannot be controlled by standard therapies.
Stay updated with the latest on the research in the program and other events involving the faculty. Read Hutch News, Science Spotlight and other published stories.